Virtual Reality Pain Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-15

Study Completion Date

2023-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Investigating pain in hospitalized patients in two groups: virtual reality usage group vs standard of care

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Virtual Reality for Pain Management Study

NCT02997085

Pain, Acute

COMPLETED NA

Virtual Reality Trial Using EaseVRx For Chronic Low Back Pain

NCT04415177

Chronic Lower Back Pain

COMPLETED NA

Patient Receptiveness to Using Virtual Reality

NCT03528668

Pain Anxiety

COMPLETED

Change in Pain With Virtual Reality-augmented Remote Rehabilitative Care

NCT05253157

Musculoskeletal Pain

COMPLETED

EaseVRx-8w+ for the Treatment of Chronic Lower Back Pain

NCT05263037

Chronic Low-back Pain Anxiety Depression

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be randomized to either the virtual reality group or the standard of care group. The virtual reality group will use the device over two days. Both groups will answer questionnaires regarding their pain and anxiety. Medical records will be used to look at pain medication usage in both groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hospitalized Patients 18 Years of Age or Older With Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Virtual Reality Group

patients will use the virtual reality device over two days

Group Type ACTIVE_COMPARATOR

EaseVRx Virtual Reality Headset

Intervention Type DEVICE

Virtual reality device with 360 degree visualization of various scenery and interactive modules

Standard of care

patients will receive standard of care only

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EaseVRx Virtual Reality Headset

Virtual reality device with 360 degree visualization of various scenery and interactive modules

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • patients at least 18 years of age,

* reported pain in last 24 hours ≥ 3 on the Numerical Rating Scales (NRS),
* patients undergoing surgery,
* expected hospital length of stay of at least 48 hours,
* English fluency,
* willing to comply with study procedures.
* Hx opioid use

Exclusion Criteria

* • gross cognitive impairment that would interfere with the ability to consent or complete study procedures

* current or prior diagnosis of epilepsy, seizure disorder, dementia, or migraines,
* hypersensitivity to flashing light or motion,
* history of motion sickness or cyber sickness,
* medical condition predisposing to or current nausea, vomiting or dizziness,
* stereoscopic vision or severe hearing impairment,
* injury to eyes, face or neck that impedes comfortable use of virtual reality,
* cancer related pain,
* PHQ-9 screen indicating suicidal ideation, patients will be referred to appropriate clinical intervention (see suicide protocol)
* currently pregnant,
* current or recent completion of participation in any interventional pain study (with in past 2 months)
* substance abuse (alcohol or illegal drugs): Alcohol- NIAAA definition of heavy drinking as more than 4 drinks on any day or more than 14 drinks per week for men, more than 3 drinks on any day or more than 7 drinks per week for women. Any illegal drugs including marijuana

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes